Skip to main content

Table 1 Review of 18 cases of malignant hepatic PEComa in adults reported in the literature

From: Malignant perivascular epithelioid cell neoplasm in the liver: report of a pediatric case

Author

Year

Sex/age

Size (cm)

Location

CT finding

MRI finding

Surgical procedure

Recurrence site

Chemotherapy

Prognosis

Dalle et al. [28]

2000

F/70

15.0

Right lobe

Hypervascular

NP

Right trisegmentectomy

Liver

NP

7 months alive from surgery

Flemming et al. [29]

2000

F/51

10 and 0.5

left lobe

NA

NA

Left lobectomy → 

Right lobectomy

Liver

NP

1.5 years alive without disease

Mizuguchi et al. [30]

2004

F/49

NA

Right lobe

Hypervascular

NA

Right trisegmentectomy

No

NP

NA

Parfitt et al. [5]

2006

F/60

14.0

Right lobe

NA

NP

Right lobectomy

Liver, trapezius, bladder, lung, and pancreas

NP

NA

Yang et al. [31]

2007

F/37

13

Left lobe

NA

NA

Extended left lobectomy

Liver, lung

NA

Died 14 months after surgery

Deng et al. [32]

2008

F/30

11

Right lobe

Hypervascular

NP

Right lobectomy

Liver, pancreas, and lung

Adjuvant

Died 4 months after recurrence

Nguyen et al. [27]

2008

F/43

11

Left lobe

Na

NA

Left hepatectomy

Liver, peritoneum, retroperitoneum, and omentum

NP

Died 3 months after surgery

Kamimura et al. [33]

2010

F/43

11.0

Left lobe

Early enhancement, wash-out in delayed phase

Low on T1I,

High on T2I

Left lobectomy

No

NP

Disease free in 3 years

Selvaggi et al. [34]

2011

F/68

9.0

Right lobe

Hypodense lesion, multiple lesions around triangular ligament, hemoperitoneum

NP

Omentectomy, toilette, hemostasis

No

NP

Died 25 days after admission

Ding et al. [35]

2011

F/31

NA

Right lobe

NA

NA

Right lobectomy

Liver

NP

Died 1 year after surgery

Kobayashi et al. [36]

2013

F/60

NA

Right lobe

Hypodense lesion, persistent enhancement

Low on T1I

High on T2I

High on DWI

Partial hepatectomy

No

NP

Disease free in 3 years

Bergamo et al. [23]

2014

M/30

18.0

Right lobe

NP

Hypervascular

Partial hepatectomy

No

Sirolimus

alive

Abhirup et al. [4]

2015

F/49

10

Right lobe

Heterogeneously enhanced with central necrosis

No

Extended right hepatectomy

Liver

NP

Died 12 months after recurrence

Wang et al. [20]

2015

F/37

9

Left lobe

Early enhancement, wash-out in delayed phase

Low on T1I

High on T2I

High on DWI

Hepatectomy → 

Liver transplantation

Liver

NP

Alive

Hao et al. [18]

2016

F/51

8.0

Right lobe

Hypodense lesion, brightly enhance, slightly local hyperattenuating

NP

Hepatectomy

NA

NP

Alive

Fukuda et al. [37]

2016

M/58

6.3

Right lobe

Early enhancement, wash-out in delayed phase

NP

Anterior segmentectomy → 

Partial pneumonectomy

Lung

NP

Recurrence free in 2 years from surgery

Liu et al. [38]

2016

M/34

15

Left lobe

Early enhancement, wash-out in delayed phase

NA

Left lobectomy

No

NP

Alive

Liu et al. [38]

2016

M/31

3

Right lobe

Early enhancement, wash-out in delayed phase

NA

Right lobectomy

No

NP

Alive

Our case

2021

M/10

13.1

Central portion

Weakly enhanced in the both arterial and portal phase

Low on T1I

High on T2I

Relatively high on DWI

Central bisegmentectomy

Thoracic vertebrae, lung and pelvis

Ifosfamide, doxorubicin/everolimus

Alive

  1. Eighteen cases were identified. Female predominance is obvious, and right lobe was more often affected. Surgical procedures most often performed were hepatic lobectomy, followed by segmentectomy, and partial hepatectomy. CT was performed for most patients, but MRI was limited in number. mTOR inhibitor was administered as neoadjuvant therapy to only one patient. F female, M male, NA information not available, NP not performed, T1I T1-weighted imaging, T2I T2-weighted imaging, DWI diffusion-weighted imaging